Kairos Pharma, LTD.

SIC Pharmaceutical Preparations
Headquarters Los Angeles, CA
Financials
FORMNAMEDATE FILED
10-K/AFY 2024 - amended4/29/202510-KFY 20244/15/2025NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4053/28/202510-QQ311/14/2024
Prospectuses and Registrations
FORMNAMEDATE FILED
424B3Prospectus4/25/2025S-1General form for registration of securities under the Securities Act of 19334/22/2025424B3Prospectus2/5/2025S-1General form for registration of securities under the Securities Act of 19331/29/2025DRSDraft Registration Statement1/3/2025S-8Securities to be offered to employees in employee benefit plans9/27/2024424B4Prospectus9/17/2024
Proxies
FORMNAMEDATE FILED
PRE 14COther preliminary information statements1/29/2025
News
FORMNAMEDATE FILED
8-KFinancial Statements and Exhibits4/28/20258-KNews Release4/24/20258-KNews Release3/20/20258-KNews Release2/26/20258-KNews Release2/6/20258-KEntry into a Material Definitive Agreement1/17/20258-KEntry into a Material Definitive Agreement1/14/2025
Ownership
FORMNAMEDATE FILED
3Singhvi Rahul4/30/20254Bhowmick Neil4/7/20254Murali Ramachandran2/24/20254Yu John S2/24/20254Murali Ramachandran11/25/20244Samuelson Doug11/25/20244Yu John S11/21/2024
Others
FORMNAMEDATE FILED
EFFECTNotice of Effectiveness4/24/2025DEF 14COther definitive information statements2/10/2025EFFECTNotice of Effectiveness2/4/2025CORRESPCorrespondence1/31/2025UPLOADSEC-generated letter1/31/2025DNotice of Exempt Offering of Securities1/28/2025EFFECTNotice of Effectiveness9/16/2024